CCL2 in the Circulation Predicts Long‐Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts
Abstract
There are few clinical predictors of the progression of systemic sclerosis (SSc)–related interstitial lung disease (ILD). The purpose of this study was to examine the predictive significance of key cytokines for long‐term progression of ILD and survival in 2 independent cohorts of patients with early SSc.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 08, 2017
- Source ID
- 10.1002/art.40171
Entities
People
- Claudia Pedroza
- Gloria A Salazar
- Janet Pope
- John D. Reveille
- Julio Charles
- Jun Ying
- Marie Hudson
- Marvin J. Fritzler
- Maureen D Mayes
- Minghua Wu
- Murray Baron
- Sandeep K. Agarwal
- Shervin Assassi
- Xiaodong Zhou
Organizations
- Baylor College of Medicine
- Jewish General Hospital
- McGill University
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
- Scleroderma Foundation
- United States Department of Defense
- University of Calgary
- University of Texas at Austin
- Western University